TELA CTO Talmo Paul buys 22,222 shares at $2.25; 4-insider cluster buy in 14 days; stock -66.1% from 52-week high.
Talmo Paul, Chief Technology Officer of TELA Bio, purchased 22,222 shares at $2.25, increasing his holdings by 32.3% to 91,082 shares total. This transaction is part of a cluster pattern in which 3 other insiders also bought within the past 14 days, suggesting coordinated or parallel conviction at depressed valuations. The stock is currently down 66.1% from its 52-week high of $7.61, though it has recovered 11.2% over the past 30 days. The company posted a net loss of $-12,600,000.00 in its latest quarter on revenue of $16,091,000.00, with full-year profitability negative; however, annual revenue growth of 41.1% indicates ongoing operational expansion despite losses. The multi-insider buy cluster during a substantial drawdown from recent highs warrants examination of whether this reflects informed expectation of stabilization or recovery.